In mice, harmol crossed the blood-brain barrier poorly, but improved glucose homeostasis and insulin sensitivity in a model of diet-induced obesity and diabetes, and delayed neuromuscular degeneration in old mice. The gene discussed is INS; the disease is obesity disorder.